Cargando…

NINTEDANIB AS AN ADJUNCT TREATMENT IN IMPROVING LUNG FUNCTION OF POST-COVID-19 PULMONARY FIBROSIS IN AN ELDERLY PATIENT: A CASE REPORT

Detalles Bibliográficos
Autores principales:	CYRIL VITUG, LAWRENCE, SANTIAGUEL, JOEL
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Pulmonary Rehabilitation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503440/ http://dx.doi.org/10.1016/j.chest.2021.07.1914

Ejemplares similares

A RETROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE THE EFFECT OF PULMONARY REHABILITATION IN PATIENTS WITH POST-COVID-19 LUNG DISEASE
por: DUMRA, PAVANJITSINGH HARJITSINGH, et al.
Publicado: (2022)

HOME OXYGENATION IN POST-COVID-19 ERA
por: PATIL, S.
Publicado: (2022)

TELE-PULMONOLOGY IN COVID-19 PANDEMIC
por: PATIL, SARANG
Publicado: (2021)

ORAL GARGLE OF ETHANOL-BASED MOUTHWASH SOLUTION AND ITS EFFECTS ON ADULT PATIENTS WITH MILD COVID-19 INFECTION: AN OPEN LABEL-RANDOMIZED CONTROLLED TRIAL
por: CYRIL VITUG, LAWRENCE, et al.
Publicado: (2021)

Effects of Nintedanib on Quantitative Lung Fibrosis Score in Idiopathic Pulmonary Fibrosis
por: Lancaster, Lisa, et al.
Publicado: (2020)

Does Tracheostomy Improve Outcomes in Those Receiving Venovenous Extracorporeal Membrane Oxygenation?
por: Boudreaux, Joel C., et al.
Publicado: (2023)

Electronic pulmonary embolism clinical decision support and effect on yield of computerized tomographic pulmonary angiography: ePE—A pragmatic prospective cohort study
por: Bledsoe, Joseph R., et al.
Publicado: (2021)

Disposition of emergency department patients with acute pulmonary embolism after ambulance arrival
por: Rouleau, Samuel G., et al.
Publicado: (2023)

Improvement in Subjective Symptoms and Tolerability in Response to Nintedanib Treatment in Elderly Patients with Idiopathic Pulmonary Fibrosis
por: Takeda, Takayuki, et al.
Publicado: (2020)

Safety and efficacy of catheter directed thrombolysis (CDT) in elderly with pulmonary embolism (PE)
por: Harrison, Eneida, et al.
Publicado: (2021)

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
por: Woodcock, Hannah V, et al.
Publicado: (2013)

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
por: Kolb, Martin, et al.
Publicado: (2017)

Can a New Scoring System Improve Prediction of Pulmonary Hypertension in Newly Recognised Interstitial Lung Diseases?
por: Sobiecka, Małgorzata, et al.
Publicado: (2020)

Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
por: Fukunaga, Kentaro, et al.
Publicado: (2018)

Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
por: Dotan, Yaniv, et al.
Publicado: (2020)

A clinical decision framework to guide the outpatient treatment of emergency department patients diagnosed with acute pulmonary embolism or deep vein thrombosis: Results from a multidisciplinary consensus panel
por: Kabrhel, Christopher, et al.
Publicado: (2021)

The Effect of Nintedanib in Post-COVID-19 Lung Fibrosis: An Observational Study
por: Saiphoklang, Narongkorn, et al.
Publicado: (2022)

Association of Circulating Proteins with Death or Lung Transplant in Patients with Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry Cohort
por: Todd, Jamie L., et al.
Publicado: (2022)

Tolerability of nintedanib in the elderly with idiopathic pulmonary fibrosis: A single-center retrospective study
por: Komatsu, Masamichi, et al.
Publicado: (2022)

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
por: Glaspole, Ian, et al.
Publicado: (2021)

Pulmonary Hamartoma Associated With Lung Cancer (PHALC Study): Results of a Multicenter Study
por: Fiorelli, Alfonso, et al.
Publicado: (2021)

Cough in Idiopathic Pulmonary Fibrosis
por: Mann, Jennifer, et al.
Publicado: (2021)

Pulmonary Hypertension Exacerbated by Nintedanib Administration for Idiopathic Pulmonary Fibrosis
por: Shimomura, Iwao, et al.
Publicado: (2018)

Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
por: Wollin, Lutz, et al.
Publicado: (2015)

Treatment with nintedanib for acute exacerbation of idiopathic pulmonary fibrosis
por: Tomioka, Hiromi, et al.
Publicado: (2017)

Efficacy and safety of nintedanib in advanced idiopathic pulmonary fibrosis
por: Yoon, Hee-Young, et al.
Publicado: (2018)

Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017)

The impact of a multicomponent-functional training with postural correction on functional balance in the elderly with a history of falling
por: Sedaghati, Parisa, et al.
Publicado: (2022)

Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib
por: Nakano, Akiko, et al.
Publicado: (2018)

Parental education and lung function of children in the PATY study
por: Slachtova, Hana, et al.
Publicado: (2010)

EVALUATION OF LUNG FUNCTION AFTER SARS-COV-2 PNEUMONIA
por: ORZES, NICLA, et al.
Publicado: (2021)

Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
por: Vizza, Carmine Dario, et al.
Publicado: (2021)

Resting pulmonary function and artery pressure and cardiopulmonary exercise testing in chronic heart failure patients in Taiwan − a prospective observational cross-sectional study comparing healthy subjects and interstitial lung disease patients
por: Chuang, Ming-Lung, et al.
Publicado: (2023)

High circulating angiopoietin-2 levels exacerbate pulmonary inflammation but not vascular leak or mortality in endotoxin-induced lung injury in mice
por: Schlosser, Kenny, et al.
Publicado: (2018)

Blood Cell Count Derived Inflammation Indexes in Patients with Idiopathic Pulmonary Fibrosis
por: Zinellu, Angelo, et al.
Publicado: (2020)

NO RELATIONSHIP BETWEEN PULMONARY FUNCTION AND EXERCISE CAPACITY IN PEOPLE WITH POSTACUTE SEQUELAE OF SARS-COV-2 INFECTION
por: BONVIE-HILL, NATALIE, et al.
Publicado: (2022)

Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib
por: Bourne, Michael H., et al.
Publicado: (2021)

The addition of echocardiographic parameters to PESI risk score improves mortality prediction in patients with acute pulmonary embolism: PESI-Echo score
por: Burgos, Lucrecia M, et al.
Publicado: (2020)

Epidemiology of pulmonary hypertension in the elderly
por: Örem, Cihan
Publicado: (2017)

Cannula Design and Recirculation During Venovenous Extracorporeal Membrane Oxygenation
por: Palmér, Oscar, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1sf9lm1dsldigpt8inhu413tnp